04.13.26 -- Scaling Regenerative Medicine Production With PolarityBio's Nikolai Sopko

Join Life Science Leader Chief Editor Ben Comer on April 30th at 11am eastern for the Return of Radiopharmaceuticals: Overcoming Operational Challenges And New Opportunities virtual event. Panelists will discuss emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers. Registration is free.

Read about how one family's race against time led to the creation of groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

Vaccine development has dramatically accelerated, with average timelines dropping 85%. Clinical trial trends show a surge in early-phase platform studies and a new focus on therapeutic cancer vaccines.

By bringing clinical research closer to where patients live and receive care, sponsors and CROs can expand reach, reduce travel burdens, and engage populations historically underrepresented in cancer studies.

Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.

Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.